Summary & Conclusions
In This Section:
FDA-Approved targeted therapies
About clinical trials
Clinical researchers are finding ways to use targeted therapies to effectively treat cancer. Since dozens of these new, innovative targeted therapies have not yet been approved by the FDA, clinical trials may be the only opportunity for patients to access them at present. Unfortunately, only 3 percent of adults with cancer choose this route and enroll in clinical trials.
A recent study indicated that 65 percent of patients would have been receptive to clinical trial enrollment if they had been made aware of the option at the time of initial diagnosis.
Eighty-seven percent would consider participating in a clinical trial if their initial treatment failed.
Physicians have the responsibility to talk to their patients about clinical trials and help them identify appropriate trials if the patients are interested.
Finding clinical trials
To do your own search for clinical trials, visit the Clinical Trials section of the National Cancer Institute's website at http://www.cancer.gov/clinicaltrials.
The NCI Web site has information about clinical trials that are sponsored by the National Cancer Institute, pharmaceutical companies, medical centers, and other groups from around the world.
There are targeted therapies for prostate cancer in all phases of clinical study. Many of these targeted therapies target the cellular processes discussed in this tutorial.
Additional information about cancer clinical trials can be found at http://bethesdatrials.cancer.gov/, which will help a patient find cancer trials at the NIH Clinical Center in Bethesda, Maryland.
For answers to additional questions about cancer, visit the National Cancer Institute's Cancer Information Service Web page at http://www.cancer.gov/aboutnci/cis.
This Web page includes a link for accessing LiveHelp, a live, online service that provides information about cancer, including information about ongoing clinical trials.
The public also may contact the Cancer Information Service at 1-800-4-CANCER.